Introduction
The theory of moist healing, put forward by George Winter in 1962, is now a widely accepted paradigm in wound management.1–3 Compared to a dry wound environment, a moist environment accelerates the healing process through multiple mechanisms. It regulates oxygen tension at the wound site, facilitates the formation of new capillaries, enhances the breakdown of necrotic tissue and fibrin, and preserves and releases active substances within the wound exudate.4–7 Additionally, a moist wound environment supports epidermal cell proliferation, differentiation and migration, maintains optimal temperature and hydration levels, and reduces the risk of infection.4–7
Traditional wound dressings, such as gauze, lint, plasters and bandages, were primarily designed to maintain wound cleanliness and prevent microbial contamination.8,9 However, these materials often adhere to the wound bed and fail to provide the moist environment conducive to optimal healing. Consequently, they have been largely supplanted by modern wound dressings, including hydrocolloids, alginates, hydrogels, foams and films, which offer improved moisture retention and reduced adherence. Given the heterogeneity of wounds in terms of location, size, depth, exudate levels, infection status and tissue adhesion, a thorough assessment of both wound characteristics and dressing properties is essential to guide the selection of the most appropriate dressing modality.2,10
Hydrogels, a type of modern wound dressing, are water-based polymers that expand upon contact with water, enabling them to retain a substantial amount of water whilst preserving their structural integrity.11,12 This capability arises from the presence of chemically or physically cross-linked polymer chains, which form a three dimensional network.11,12 Given that hydrogels are composed of more than 90% water, they provide a moist wound environment conducive to tissue regeneration.13,14 Through chemical modifications, hydrogels can be engineered into solid, semi-solid, or liquid forms, allowing for versatile applications in wound care.11 These characteristics, along with additional properties such as high porosity, responsiveness to external stimuli, soft and flexible structure, and biomimetic resemblance to living tissue, make hydrogels a highly promising material for advanced wound care applications.11,14,15 Furthermore, hydrogels can serve as effective carriers for antibacterial and antimicrobial agents, cells, biomolecules and growth factors, enhancing their potential for controlled drug delivery and tissue engineering applications.12
Dermatix (Registered trademark, Menarini, Singapore) Wound Care (DWC) gel is a paraben-free, unmedicated, acidified hydrogel that forms a semi-occlusive, breathable protective film on the wound.16 It is composed of an acidic carbomer in water stabilized by carnosine, a basic dipeptide naturally present in the skin, and a percentage of fatty substances that help reduce the evaporation of water.16 The carbomer in this ‘smart’ or ‘intelligent’ hydrogel is responsible for the principle mechanism of action of DWC gel.12,16 In dry wounds, it acts as a moisture-retentive barrier, inhibiting transepidermal water loss and preventing evaporation whilst hydrating the wound bed. Conversely, in exudative wounds, the carbomer exhibits fluid-absorptive properties, effectively managing excess wound exudate.16 This bifunctional activity enables the hydrogel to maintain an optimal moist wound environment across varying wound conditions.16 Additionally, the acidity of the carbomer keeps the pH of the wound low, deterring microbial growth.16
Herein, we explore the effectiveness of DWC gel in acute and chronic wounds of diverse aetiologies in patients in Asia. Through a series of case studies, we present our early experience with DWC gel, alone and in conjunction with other modalities, for the treatment of acute and chronic wounds in centres in Singapore, Vietnam, Malaysia and Indonesia. We also provide our expert opinion, based on our practical experience, on the landscape of wound management in Asia and the role of DWC gel in wound healing.
Methods
The expert panel comprised of eight clinicians, including dermatologists (n=3), orthopaedic surgeons (n=4) and a plastic surgeon (n=1). The experts have extensive experience in managing different types of wounds in their routine clinical practice and represent diverse countries, healthcare settings and systems across Asia. The expert panel met in November 2024 to share their experience of using DWC gel – they presented case studies from their practice and participated in discussions on the role of DWC gel in individual cases.
The case series includes 16 patients with wounds treated with DWC gel alone or in combination with other modalities. The cases included in the case series were anonymized and de-identified.
Before the meeting, the expert panel completed a survey that assessed their opinion, based on their clinical practice, on the current landscape of wound care management and the role of DWC gel in wound healing. The survey presented 19 statements for each of which the respondents chose from the following response options: ‘Agree’, ‘Somewhat agree’ or ‘Disagree’; the expert panel had the opportunity to provide clarification of their choice and any further inputs. These statements and the panel’s responses were further discussed at the meeting.
Case series
The cases presented at the meeting included acute (n=9) and chronic (n=7) wounds (Table 1).
Acute wounds
In acute superficial wounds with no signs of infection and little to no exudate (Cases 1 and 2), DWC gel used alone (applied two to three times a day) led to complete wound healing with minimal to no post-inflammatory hyperpigmentation and no scarring (Figures 1 and 2).
In a patient with an acute, infected ulcer secondary to a ruptured furunculosis (Case 3; Figure 3A), thrice daily application of DWC gel in conjunction with topical and oral antibiotics resulted in complete re-epithelialization of the wound in 2 weeks (Figure 3B). The patient’s concern regarding the aesthetically sensitive location of the wound was addressed with easy at-home management.
A patient who presented with painful haemorrhagic ulcers on the lips, secondary to mycoplasma infection (Case 4; Figure 4A), required multimodal treatment to treat the pain and the infected ulcers, including topical and intravenous antibiotics, topical DWC gel, and intravenous antivirals and analgesics. At presentation, the patient was in severe pain and dysfunction due to lip ulcers; she was unable to eat or drink and found it difficult to speak. The crust on the ulcers softened with frequent DWC gel application (four times/day) and was removed gently, and the ulcer or erosions underneath achieved complete re-epithelization in 1 week (Figure 4B).
Poor healing wounds
Following a dermal filler injection on the nose, a patient presented with a poor-healing ulcer (3 months) on the radix (Case 5; Figure 5A). She had received oral antibiotics for 1 week following the injection and topical mupirocin for 3 months, but the wound did not heal completely. Treatment with topical DWC gel for 4 weeks, followed by two sessions of intralesional steroid injection plus intense pulsed light (IPL) plus fractional CO2, and two sessions of IPL plus fractional CO2, and Dermatix Ultra gel for 3 months, led to complete wound healing with minimal post-inflammatory hyperpigmentation (Figure 5B).
A patient who was treated with radioactive Phosphorus 32 paste from 1989 to 1991 for a haemangioma on the left shoulder and continued to receive treatment in 2008, presented with poor-healing ulcers with a duration of 10 years (Case 6; Figure 6A). Topical DWC gel applied to the ulcers for 8 weeks resulted in significant healing of the wound (Figure 6B). At 8 weeks, DWC gel was discontinued, and Dermatix Ultra gel was initiated along with three sessions of IPL plus fractional CO2 plus intralesional steroid injections and six sessions of IPL plus fractional picosecond laser, which resulted in complete healing of the ulcers with a hypertrophic scar remaining at 6 months (Figure 6C).
Traumatic wounds
Traumatic wounds (Cases 7 and 8; Figures 7A and 8A) showed complete re-epithelialization and healing following surgical debridement and topical DWC gel application (Figures 7B and 8B). Topical DWC gel was applied on dry gauze to cover the wounds, which were then wrapped with elastic bandage; the dressing was changed daily for the first 2 weeks and then every other day for 2 weeks. The wound beds, which were covered with healthy granulation tissue after debridement, underwent progressive epithelialization over 4 weeks (Figures 7C and 8C).
Post-surgical wounds
A post-operative incisional wound (Case 9; Figure 9A) in a patient who underwent surgery to correct flexion contracture of the right elbow with malunion of the right distal humerus healed completely with no gap in 4 weeks with topical DWC gel used with a topical antibiotic dressing (Figure 9B).
In a patient who underwent surgery to remove a myxofibrosarcoma over the right ankle (wide excision with anterolateral thigh flap; Case 10; Figure 10A), the surgical wound healed significantly with a combination of negative pressure wound therapy during the initial 4–5 days, and topical DWC gel and topical antibiotic dressing for 7 weeks (Figure 10B,C). The anterolateral thigh flap was thick, and the peripheral area of the flap was compromised with exposure of the tendon and surgical plate from the ankle arthrodesis anteriorly (Figure 10B). However, the wound healing progressed satisfactorily with growth of the granulation tissue even over the implant (Figure 10C).
Chronic wounds
Topical DWC gel was shown to promote wound healing in chronic diabetic foot ulcers (Cases 11, 12, 13), pressure ulcers (Case 14), venous ulcers (Case 15) and vasculitic ulcers (Case 16).
A 58-year-old patient with a history of diabetes and hypertension developed a foot ulcer that did not heal despite the use of multiple hydrogels along with antimicrobial and secondary foam dressings over 5 months (Case 11; Figure 11A). The ulcer showed remarkable improvement over 3 weeks following wound debridement and DWC gel applied with a secondary polyurethane membrane dressing (Figure 11B). At the end of 3 weeks, shockwave therapy was introduced as an adjunct with once-weekly sessions for 3 weeks.
By 7 weeks, the wound had healed with >90% epithelialization (Figure 11C). The patient was satisfied with DWC gel because it was simple and convenient to use.
A non-healing ulcer (>2 months duration) on the plantar aspect of the left forefoot in a patient with a history of diabetes (Case 12) improved with granulation and epithelization in 3 months with DWC gel dressing (changed every other day) after wound debridement (Figure 12A–C). Given the location of the ulcer, off-loading was recommended, but the patient was non-compliant. Although a part of the wound over the flexor tendon of the big toe remained exposed at the end of 3 months, it was covered with healthy granulation tissue.
The patient was satisfied with the progress of wound healing.
In an 82-year-old woman with multiple comorbidities, including diabetes, a foot ulcer on the medial plantar aspect of the right foot initially managed with debridement followed by daily dressing at home or primary care clinic did not lead to any improvement in the wound. Local mechanical and sharp debridement followed by application of DWC gel and contact layer with superabsorbent foam (dressing changed every 2 days) resulted in significant wound improvement over 3 months (Case 13; Figure 13). Wound healing was sped up with the assistance of DWC gel as well as patient education and diabetes control.
An infected pressure ulcer in the sacral area (Case 14; Figure 14A) of a bed-bound patient with paraplegia and diabetes was initially managed with debridement followed by intermittent use of negative pressure therapy with wound instillation for 3 months and without instillation for a further 3 weeks, leading to resolution of the infection and improvement in the wound (Figure 14B,C). Thereafter, application of DWC gel alternating with a hydrocolloid paste for chemical debridement and silver-based non-woven dressing for 3 months led to a marked reduction in the wound size with a remnant punctate ulcer (Figure 14D).
In a patient with a history of hypertension and previous venous ulcers (Case 15), who presented with four non-healing (>10 months) and heavily exudative venous ulcers of varying sizes on the left lower leg, application of DWC gel with superabsorbent pad dressing or polyurethane membrane as secondary dressing and compression bandage for 15 weeks led to complete epithelialization of all but one ulcer, which was also markedly reduced in size and 85% epithelialized (Figure 15A–F).
A chronic non-healing ulcer (>2 years) on the right ankle of a patient with polycythaemia vera and autoimmune vasculitis on treatment with hydroxyquinone and interferon therapy, showed no significant improvement despite several months of negative pressure therapy and 40 cycles of hyperbaric oxygen therapy (Case 16; Figure 16A). The ulcer improved markedly over 4 months, and the edges became flat and flush with the ulcer following conservative wound debridement, gentle removal of slough and topical DWC gel application (Figure 16B,C).
Expert opinion
All survey responses are summarized in Table 2.
The expert panel acknowledged that, whilst cleansing the wound alone is not sufficient for wound care and management, it remains an essential first step in the process (Statement 1). They also unanimously agreed that poor wound care and management could contribute to poor scarring (Statement 2).
Concerning the landscape of wound care management, the panel noted that, though there is an increasing understanding of antibiotic resistance among healthcare providers, the general public continues to use antibiotic creams for wounds routinely due to a lack of education and awareness, and fear of complications (Statements 3 and 4).
All experts agreed that a moist wound environment promotes wound healing in most wounds; however, for certain wounds, such as arterial wounds or ulcers or gangrenous wounds, a dry environment is more appropriate (Statement 5). Hydrogels provide an optimal moist environment conducive to wound healing. However, improper selection and application without an understanding of individual constituents could be detrimental (Statements 6 and 7).
The case studies presented by the experts demonstrated that DWC gel helps with granulation and epithelialization and is particularly useful in the third and fourth stages of wound healing – proliferation and remodelling – and accelerates the wound healing process (Statement 8). The experts broadly agreed that DWC gel’s intelligent technology seems to help regulate wound moisture but highlighted the need for comparative head-to-head trials versus other hydrogels (Statement 9). There was agreement on the impact of carnosine, a key component of DWC gel, in accelerating wound healing; further discussion highlighted the need for studies to elucidate the role of carnosine in wound healing (Statement 10).
The expert panel also agreed that DWC gel with its white colour allows for good visualization of the demarcation for application on wounds (Statement 11). As elucidated in the case studies, DWC gel appears to provide a cooling effect and pain relief, and reduces itchiness in the wound, but the role of DWC gel in preventing wound infection is not believed to be clearly evidenced and needs further evaluation (Statements 12 and 13). There was unanimous agreement on the safety of DWC gel when used on non-mucosal skin (e.g. trunks, limbs, face) (Statement 14).
The expert panel agreed that DWC gel is suitable for use in (Statements 15, 16 and 17):
However, the panel identified certain scenarios where DWC gel may not be appropriate, including fresh surgical wounds, where excess moisture could cause edge maceration, and in infected wounds, where bioburden must first be adequately controlled. On allergy-prone skin, DWC gel should be used on a case-by-case basis – the constituents of the gel need to be carefully considered (Statement 18). A majority of experts also agreed that DWC gel is safe to be used in pregnant or lactating women and children (Statement 19).
Discussion
Case series
The case series illustrates the efficacy and safety of DWC gel in the management of acute and chronic wounds of varying aetiologies – traumatic, post-procedure complications, allergic dermatitis, post-surgical, diabetic foot ulcers, venous ulcers, vasculitic wounds and pressure ulcers – in real-world settings.
In all the case studies presented, patients were satisfied with the improvement in their wounds; DWC gel was easy and convenient for patients to use at home, and this contributed to good adherence to the regimen. It spreads easily, even on dry and crusted ulcers, and remains adherent to the wound surface for prolonged periods. DWC gel can be used alone as monotherapy (Cases 1 and 2) and can be combined with other modalities, such as shockwave therapy or secondary dressings, as illustrated in cases 4, 10, 11 and 14–16.
In acute superficial wounds, DWC gel promoted wound healing with minimal scarring and little to no post-inflammatory hyperpigmentation; this is cosmetically desirable for most patients (Cases 1–3). In the 16 case studies presented here, as well as in the clinical experience of the expert panel, there were no safety signals, and there were no patient complaints of itching or discomfort with DWC gel.
The results demonstrated in the case series presented here, particularly for superficial wounds, are in line with those seen in a clinical study.16 A within-person, single-centre, randomized, investigator-blind clinical study compared a DWC gel-treated test field with an untreated test field in an abrasive wound model. The study reported that treatment of superficial cutaneous wounds with DWC gel resulted in improved wound healing as demonstrated by faster wound closure and a considerably better cosmetic appearance, whilst providing immediate cooling.16
Chronic wounds, often referred to as a silent epidemic, pose a substantial global burden not only at the individual level but also across healthcare systems worldwide.17–19 Whilst data on the prevalence of chronic wounds in Asia remain limited, a recent systematic review and meta-analysis highlights their high prevalence across Asian populations, particularly in resource-constrained settings.19 The burden of chronic wounds in this region is shaped by socioeconomic factors such as literacy rates, healthcare infrastructure and access to medical services.18,19 Given the heterogeneity of populations and healthcare systems across Asian countries, there is a pressing need for region-specific studies to better characterize the epidemiology and impact of chronic wounds. Furthermore, the development of standardized clinical practice guidelines adaptable to local contexts may enhance clinician support and improve the management of chronic wounds in diverse settings.
Through Cases 11–16, we have highlighted the importance of a multimodal, multidisciplinary approach for the effective management of chronic or hard-to-heal wounds, as these wounds are often influenced by a complex interplay of physiological, social and behavioural factors. Collaboration among healthcare professionals, including wound care specialists, dermatologists, surgeons, nurses and nutritionists, ensures a comprehensive treatment plan that addresses not only the wound itself but also underlying conditions such as diabetes, vascular insufficiency and infection. Patient education plays a pivotal role in this process, empowering patients or their caregivers to adhere to treatment regimens, recognize early signs of complications, and adopt lifestyle modifications that support healing.
The TIMERS framework (Tissue management, Inflammation control, Moisture balance, Edge advancement, Regeneration-Repair, and Social factors) provides a structured approach to managing hard-to-heal wounds. Importantly, social- and patient-related factors, such as socioeconomic status, access to healthcare, adherence to treatment and mental health, significantly influence wound healing outcomes.20 Addressing these barriers through tailored patient support, improved healthcare accessibility, and multidisciplinary collaboration enhances the efficacy of wound care strategies, ultimately leading to better healing and quality of life for patients.
Expert opinion
Overall, there was agreement that DWC gel promotes wound healing in acute and chronic wounds. However, there are unmet needs and challenges that need to be addressed, and the expert panel recommended further studies or investigations, including head-to-head clinical trials comparing the effect of DWC gel in wound moisture regulation versus that of other hydrogels.
Furthermore, laboratory studies to assess the anti-infective and anti-inflammatory properties of DWC gel, particularly carnosine, will also shed light on the impact of this component. Carnosine, an endogenous dipeptide (constitutive amino acids: L-histidine and β-alanine), has a multimodal mechanism of action, including anti-aggregant, anti-inflammatory and antioxidant properties.21,22 It acts as an L-histidine precursor, thus regulating histamine synthesis during trauma; faster wound healing through histamine is associated with the activity of basic fibroblast growth factor, leading to macrophage recruitment and angiogenesis; carnosine also stimulates collagen biosynthesis through the β-alanine component.23,24 In animal models, carnosine has been shown to promote wound healing,25–27 but further studies to characterize the role of carnosine in wound healing in humans are warranted.
Limitations
The opinion and experience presented in this paper are based on early use of DWC gel, and whilst the findings provide valuable preliminary insights, longer-term use will provide deeper insights and a more comprehensive understanding of its performance and potential applications. The expert panel consisted of eight wound care specialists who contributed two case studies from their respective practices. Whilst the case series and the expert opinion provide a representative perspective of wound care practices in the Asia region, the reliance on anecdotal data and the small sample size limit the generalizability of the findings and have the potential to introduce bias.
Additionally, the case studies reflect real-world clinical experiences from different countries and healthcare settings, leading to variability in wound assessment and image documentation. This inconsistency may impact the comparability of cases. Last, outcomes in the case studies were not assessed using objective efficacy measures or validated wound assessment tools, limiting the ability to quantify the impact of DWC gel on wound healing outcomes.
Future studies with larger sample sizes, standardized wound assessment protocols and objective outcome measures are warranted to validate these preliminary observations.
Conclusion
This case series of acute and chronic wounds, including traumatic wounds, post-procedure complications, post-surgical wounds, diabetic foot ulcers, venous ulcers, vasculitic wounds and pressure ulcers, demonstrated the efficacy and safety of DWC gel in wound care and management. The expert opinion, based on the clinical experience of the panel, supports the use of DWC gel for managing acute and chronic wounds, alone and with other modalities of treatment as appropriate. A collaborative wound management approach is crucial for managing chronic or hard-to-heal wounds as these are influenced by a complex interplay of physiological, social and behavioural factors.
Utilizing the TIMERS framework, enhancing patient education, and addressing social determinants of health through tailored support and collaboration can significantly improve wound healing outcomes and overall patient well-being.